I am deeply concerned about the recent attacks on humanitarian operations in Dikwa and Damasak, affecting humanitarian assets and personnel. We have temporarily suspended operations in these areas in order to safely relocate humanitarian staff and are closely monitoring the situation. We intend to resume operations as soon as possible, so that civilians affected by the conflict continue to receive the assistance they need. I condemn in the strongest terms attacks on civilians and civilian infrastructure which may constitute violations on International Humanitarian Law.

Abuja, 16 March 2021- Ongoing conflict continues to be the main driver of humanitarian needs in northeast Nigeria, where millions of people have been displaced. Longstanding insecurity and violence, compounded by climate change, and the impact of Covid-19 are increasing the vulnerability of close to nine million people. Close to two million people are internally displaced, while millions of people depend on humanitarian partners for basic services, and up to 5.1 million people are facing hunger in the lean season – the worst outlook in four years. The humanitarian community and the Government of Nigeria officially launched the north-east Nigeria Humanitarian Response Plan for 2021 earlier today. The plan requests US$1 billion to enable partners to provide critical services to the 6.4 million most vulnerable people - amongst a total of 8.7 million people in need of some form of humanitarian assistance in 2021. “The humanitarian crisis in Borno, Adamawa, and Yobe states, unfortunately, remains one of the largest in the world and continues to have a profound impact on Nigeria and its people, causing untold suffering and deprivation for millions of vulnerable women, men and children. The year 2021 marks the twelfth year of the conflict and the sixth year of the international community working together with the Government of Nigeria to provide humanitarian support,” said the United Nations Resident and Humanitarian Coordinator in Nigeria, Edward Kallon. “Last year was a challenging year for vulnerable people in north-east Nigeria.
It was a year marked by a new reality, the COVID-19 pandemic. The socio-economic impact of the pandemic has already diminished the resilience of millions of people, increasing the fragility of those who were already extremely vulnerable,” he added. “The requirements for this 2021 Humanitarian Response Plan reflect a growing need, while we know that the available resources will very likely not be commensurate with those needs”, said the Honourable Minister of Humanitarian Affairs, Disaster Management and Social Development Hajiya Sadiya Umar Farouq. “We are facing additional challenges in terms of security and access for humanitarian partners, which is why we have developed the National Humanitarian Development Peace Framework”, she added.
A combination of escalating conflict, displacement, and disruption to and loss of livelihoods due to COVID19 restrictions, could lead to hunger for millions of Nigerians living in the north-east. As many as 5.1 million people are threatened by acute hunger during the upcoming lean season – the worst outlook in four years. The humanitarian community remains committed to working closely with the Government of Nigeria and local communities to reduce protection risks, provide basic services, including shelter, health, water and sanitation, education, as well as food and nutrition and, moreover, livelihood opportunities. The operation will increasingly seek to identify longer-term or durable solutions for those displaced, restoring dignity, self-reliance and hope for a better future, where possible. “The main thrust of the operation in 2021 will continue to be providing lifesaving and life-sustaining support to people who are displaced, host communities, and others that are affected by the humanitarian crisis”, said Mr. Kallon. “This includes improving the living conditions in camps through decongestion and enhancing the quality of services. We will continue to prioritize prevention, development where feasible and humanitarian assistance where needed. A durable framework to find solution to the crisis in north east Nigeria must promote and implement the humanitarian, development and peace nexus,” he added. “In 2020 the Government took major steps to strengthen its coordination and leadership role and structures at federal and state levels to bring better coherence to addressing humanitarian needs, while laying the foundation for stabilization and development of conflict-affected states,” said the Honourable Minister. “One of these steps includes the inauguration of the National Humanitarian Coordination Committee, which is the highest national advisory body to guide humanitarian activities in the country,” she added. In 2020, only 55 per cent of the required funding for the Humanitarian Response Plan was secured notwithstanding the additional needs created by the COVID-19 pandemic, recording the lowest funding level since the beginning of the joint response. Nevertheless, humanitarian partners reached over five million people with potentially lifesaving services despite funding shortfalls, security challenges and movement restrictions caused by the ongoing violence and the COVID-19 pandemic. Malnutrition was averted for over two million children through their provision with fortified nutritious foods to address or prevent malnutrition, and two million people were reached with protection services, including sexual and gender-based violence prevention and response, enhanced mine awareness, and support in addressing housing land and property concerns. For further information, please contact:
Sandy MAROUN, Public Information Officer, OCHA Nigeria, (+234) 906 227 7205, sandy.maroun@un.org

3 March 2021 BRAZZAVILLE – Africa’s regional know-how, assets and policy expertise will be more systematically channeled to the Resident Coordinators and United Nations Country Teams (UNCTs) across the continent as they help countries ensure an inclusive and sustainable transition out of the COVID-19 crisis, UN Deputy Secretary-General and Chair of the UN Sustainable Development Group Amina J. Mohammed stressed as she joined the first annual meeting of the new Regional Collaborative Platform on 2 March 2021. “Today marks the start of the next-generation collaboration approach for the regional UN entities to support African countries to respond and recover better from the COVID-19 pandemic and reignite the Decade of Action for the 2030 Agenda for Sustainable Development, which is aligned with the Africa Union Agenda 2063,” Ms. Mohammed said. The United Nations has been making progress on its sweeping reforms to strengthen its support to countries, leveraging its capacities at all levels. The new Regional Collaborative Platform has responded to the growing need for enhanced UN coordination and regional collaboration in the face of the pandemic and implementation of the Sustainable Development Goals. It brings together UN regional expertise, capacity and data to provide analytical, policy and operational support to countries. Yesterday’s discussion, attended by regional representatives from the Africa UN development system, focused on high-priority issues for the African continent to recover better from the pandemic and move toward the Sustainable Development Goals. These included accelerating the implementation of the continental free trade agreement; investing in youth and women’s empowerment to help countries reap the benefit of their demographic dividends; advancing home-grown sustainable and scalable technologies and digital solutions; building climate and disaster resilience; and continuing to support the African Union’s “Silencing the Guns” initiative. Across the continent, Resident Coordinators and UNCTs are supporting countries in their access to COVAX vaccines and their socioeconomic response plans. In addition to the pandemic recovery, UN entities will work together to support sustainable development efforts in the Sahel, the Lake Chad Basin and the Horn of Africa, and address the resurgence of Ebola, and climate crises with severe damage caused by deadly droughts, cyclones and locust outbreaks. “We are still in a recovery phase for the continent. We need additional resources. Our low- and middle-income countries, as well as small island states, have lost a lot of their resources. They need more fiscal space. They need more revenues. They need additional liquidity to ensure we build forward better,” said Under-Secretary-General Vera Songwe, Executive Secretary of the UN Economic Commission for Africa (UNECA). Although it was a transitional year, the regional UN entities demonstrated evidence of enhanced system-wide collaboration at the regional level. For example, last year, all of them joined forces to launch the Knowledge Management Hub on COVID-19 and shared a business continuity plan with governments to support their e-governance, e-justice and e-commerce for livelihoods, while the Africa e-education strategy was introduced to Resident Coordinators to provide emergency education to more than 100 million African children out of school. “The African region is at a strategic juncture with COVID-19 recovery programmes and investments that we are making to enhance trade. All our efforts will yield desired results only if Africa’s people – our most important resource – feel productive, if they feel valued, if they feel safe, and if they feel secure,” said Assistant Secretary-General Ahunna Eziakonwa, Director of the Regional Bureau for Africa at the UN Development Programme (UNDP). The new platform will engage with the African Union in April and accelerate its effort to deliver on its promise with an impact-oriented focus on implementations. The Regional Collaborative Platform is chaired by the UN Deputy Secretary-General with two Vice-Chairs: Ms. Songwe and Ms. Eziakonwa. Its joint secretariat is comprised of UNECA, UNDP and the UN Development Coordination Office (DCO).                                                                                      ### Notes for correspondents Agenda 2063 is Africa’s blueprint and master plan for transforming Africa into the global powerhouse of the future. It is the continent’s strategic framework that aims to deliver on its goal for inclusive and sustainable development. The UN Resident Coordinator system encompasses all organizations of the United Nations system dealing with operational activities for development, regardless of their formal presence in the country. Screenshots of the meeting can be downloaded here (©UNDCO).   Media contacts Hiroyuki Saito, Regional Communications Officer Regional Office for Africa, UN Development Coordination Office saitoh@un.org Maleele Choongo Regional Bureau for Africa, UN Development Programme Maleele.choongo@undp.org    

Press statement COVID-19 vaccines shipped by COVAX arrive in Nigeria Abuja, 2 March 2021 - Today, Nigeria received nearly 4 million doses of the COVID-19 vaccine, shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO. The arrival marked a historic step towards the goal to ensure equitable distribution of COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals in Nigeria that will continue in the coming days and weeks. COVAX shipped 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India (SII), from Mumbai to Abuja. “The UN Country Team in Nigeria reiterates its commitment to support the vaccination campaign in Nigeria and help contain the spread of the virus,” said Edward Kallon, UN Resident Coordinator in Nigeria. “The arrival of these vaccines in Abuja today marks a milestone for the COVAX Facility in its unprecedented effort to deliver at least 2 billion doses of COVID-19 vaccines globally by the end of 2021.” The arrival of the CIVID-19 vaccine will enable the National Primary Health Care Development Agency (NPHCDA) to commence the vaccination of Nigerians in priority groups, starting with frontline healthcare workers. “This is a landmark moment for the country and the COVAX Facility’s mission to help end the acute phase of the pandemic by enabling equitable access to these vaccines across the world. We are glad to see Nigeria is amongst the first receiving the doses from COVAX, thanks to the excellent level of preparedness put in place by the Government of Nigeria,” said Thabani Maphosa, Managing Director for Country Programmes at Gavi, the Vaccine Alliance. “Gavi looks forward to these vaccines being made available to the people most at risk, as soon as possible, and to ensuring that routine immunization services for other life-threatening infections are also delivered to avoid other disease outbreaks.” Dr Walter Kazadi Mulombo, WHO Representative in Nigeria, said: “It is heart-warming to witness this epoch-making event and WHO wishes to congratulate the government of Nigeria for its participation in the global vaccine collaboration (COVAX) efforts and its commitment to protecting Nigerians against this pandemic. Vaccines are a critical new tool in the battle against COVID-19; therefore, this is a step in the right direction. These vaccines have undergone rigorous regulatory processes at global and country level and have been deemed safe and effective.” The COVAX Facility is expected to deliver around 90 million doses of COVID-19 vaccines to the African Region in the first quarter of 2021 and has committed to providing up to 600 million doses to the region by end-2021 to cover 20 per cent of the population. “After a year of disruptions due to the COVID-19 pandemic, today we celebrate the efforts being made in getting the vaccine to Nigeria. With more than 150,000 Nigerians infected with the virus and over 1,800 lives lost, the path to recovery for the people of Nigeria can finally begin,” said Peter Hawkins, UNICEF Nigeria Country Representative. “This is a very significant occasion - the arrival of the COVID-19 vaccines into Nigeria is critical in curbing the pandemic. The only way out of this crisis is to ensure that vaccinations are available to all.” The COVAX Facility thanks the governments, foundation and other donors who contributed to making this milestone happen – including the generous support of the European Commission, countries of the European Union, Japan, the United Kingdom and the United States. For a full list of donors, please see here. For several months, COVAX partners have been supporting governments and partners in readiness efforts, in preparation for this moment. They have been especially active in working with some of the world’s poorest countries: those that will benefit from the Advance Market Commitment (AMC), an innovative financial mechanism to help secure global and equitable access for COVID-19 vaccines. This includes assisting with the development of national vaccination plans, support for cold chain infrastructure, as well as stockpiling of half a billion syringes and safety boxes for their disposal, masks, gloves and other equipment to ensure that there is enough equipment for health workers to start vaccinating priority groups as soon as possible. In order for doses to be delivered to COVAX Facility participants via this first allocation round, several critical pieces must be in place, including confirmation of national regulatory authorisation criteria related to the vaccines delivered, indemnification agreements, national vaccination plans from AMC participants, as well as other logistical factors such as export and import licenses. As participants fulfil the above criteria and finalise readiness preparations, COVAX issues purchase orders to the manufacturer and ships and delivers doses via an iterative process. This means deliveries for the first round of allocation are taking place on a rolling basis and in tranches.   COVAX is co-led by Gavi, the Vaccine Alliance, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI), working in partnership with UNICEF, the World Bank, civil society organisations, manufacturers, and others. COVAX is part of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.  COVAX has built a diverse portfolio of vaccines suitable for a range of settings and populations, and is on track to meet its goal of delivering at least 2 billion doses of vaccine to participating countries around the globe in 2021, including at least 1.3 billion donor-funded doses to the 92 lower-income COVAX Facility participants supported by the Gavi COVAX AMC.    Media contacts UN in Nigeria Oluseyi Soremekun: +234 803 303 0002, soremekun@un.org GAVI Meghana Sharafudeen: +41 79 711 55 54 msharafudeen@gavi.org Evan O'Connell +33 6 17 57 21 26 econnell@gavi.org   UNICEF Nigeria Geoffrey Njoku, UNICEF Nigeria, +234 803 525 0288, gnjoku@unicef.org Safiya Akau, UNICEF Nigeria, +234 706 418 4023, sakau@unicef.org WHO Nigeria Charity Warigon, WHO Nigeria, +234 810 221 0093, warigonc@who.int   Notes to Editors List of donor pledges to the Gavi COVAX AMC is available here. Interactive funding tracker for the ACT Accelerator, which includes details of funding for COVAX, can be found here. About COVAX COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance Gavi) and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries. CEPI is focused on the COVAX vaccine research and development portfolio: investing in R&D across a variety of promising candidates, with the goal to support development of three safe and effective vaccines which can be made available to countries participating in the COVAX Facility. As part of this work, CEPI has secured first right of refusal to potentially over one billion doses for the COVAX Facility to a number of candidates, and made strategic investments in vaccine manufacturing, which includes reserving capacity to manufacture doses of COVAX vaccines at a network of facilities, and securing glass vials to hold 2 billion doses of vaccine. CEPI is also investing in the ‘next generation’ of vaccine candidates, which will give the world additional options to control COVID-19 in the future.   Gavi is focused on procurement and delivery for COVAX: coordinating the design, implementation and administration of the COVAX Facility and the Gavi COVAX AMC and working with its Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery. The COVAX Facility is the global pooled procurement mechanism for COVID-19 vaccines through which COVAX will ensure fair and equitable access to vaccines for all 190 participating economies, using an allocation framework formulated by WHO. The COVAX Facility will do this by pooling buying power from participating economies and providing volume guarantees across a range of promising vaccine candidates. The Gavi COVAX AMC is the financing mechanism that will support the participation of 92 low- and middle-income countries in the Facility, enabling access to donor-funded doses of safe and effective vaccines. Gavi is fundraising for the COVAX AMC, and funding UNICEF procurement of vaccines as well as partners’ and governments work on readiness and delivery, including support cold chain equipment, technical assistance, syringes, vehicles, and other aspects of the vastly complex logistical operation for delivery. UNICEF and the Pan-American Health Organisation (PAHO) will be acting as procurement coordinators for the COVAX Facility, helping deliver vaccines to COVAX AMC participants and others. WHO has multiple roles within COVAX: It provides normative guidance on vaccine policy, regulation, safety, R&D, allocation, and country readiness and delivery. Its Strategic Advisory Group of Experts (SAGE) on Immunization develops evidence-based immunization policy recommendations. Its Emergency Use Listing (EUL)/prequalification programmes ensure harmonized review and authorization across member states. It provides global coordination and member state support on vaccine safety monitoring. It developed the target product profiles for COVID-19 vaccines and provides R&D technical coordination.  WHO leads, along with UNICEF, the support to countries as they prepare to receive and administer vaccines. The Country Readiness and Delivery (CRD) workstream includes Gavi and numerous other partners working at the global, regional, and country-level to provide tools, guidance, monitoring, and on the ground technical assistance for the planning and roll-out of the vaccines.  Along with COVAX partners, WHO is also developing a no-fault compensation scheme as part of the time-limited indemnification and liability commitments. UNICEF is leveraging its experience as the largest single vaccine buyer in the world and working with manufacturers and partners on the procurement of COVID-19 vaccine doses, as well as freight, logistics and storage. UNICEF already procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries. In collaboration with the PAHO Revolving Fund, UNICEF is leading efforts to procure and supply doses of COVID-19 vaccines for COVAX. In addition, UNICEF, Gavi and WHO are working with governments around the clock to ensure that countries are ready to receive the vaccines, with appropriate cold chain equipment in place and health workers trained to dispense them. UNICEF is also playing a lead role in efforts to foster trust in vaccines, delivering vaccine confidence communications and tracking and addressing misinformation around the world. About CEPI CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines to stop future epidemics. CEPI has moved with great urgency and in coordination with WHO in response to the emergence of COVID-19. CEPI has initiated 11 partnerships to develop vaccines against the novel coronavirus. The programmes are leveraging rapid response platforms already supported by CEPI as well as new partnerships. Before the emergence of COVID-19, CEPI’s priority diseases included Ebola virus, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever and Chikungunya virus. CEPI also invested in platform technologies that can be used for rapid vaccine and immunoprophylactic development against unknown pathogens (Disease X). About Gavi Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in 73 developing countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here. About WHO The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing.
 
For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on Twitter, Facebook, Instagram, LinkedIn, TikTok,  Pinterest, Snapchat, YouTube About UNICEF UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and its work for children, visit www.unicef.org. For more information about COVID-19, visit www.unicef.org/coronavirus . Find out more about UNICEF’s work on the COVID-19 vaccines here, or about UNICEF’s work on immunization here. Follow UNICEF on Twitter and Facebook.   About the ACT-Accelerator The Access to COVID-19 Tools ACT-Accelerator, is a new, ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March and launched by the WHO, European Commission, France and The Bill & Melinda Gates Foundation in April 2020. The ACT-Accelerator is not a decision-making body or a new organisation, but works to speed up collaborative efforts among existing organisations to end the pandemic. It is a framework for collaboration that has been designed to bring key players around the table with the goal of ending the pandemic as quickly as possible through the accelerated development, equitable allocation, and scaled up delivery of tests, treatments and vaccines, thereby protecting health systems and restoring societies and economies in the near term. It draws on the experience of leading global health organisations which are tackling the world’s toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19. Its members share a commitment to ensure all people have access to all the tools needed to defeat COVID-19 and to work with unprecedented levels of partnership to achieve it. The ACT-Accelerator has four areas of work: diagnostics, therapeutics, vaccines and the health system connector. Cross-cutting all of these is the workstream on Access & Allocation.